Your Dose of Cannabis Education
Your Dose of Cannabis Education
Only have a minute but want to Learn something every day™? Sign up to receive Your Dose of Cannabis Education, bringing featured content from our course library right to your inbox each day.
Your Dose of Cannabis Education is based on data from the studies and reviews published in the current peer-reviewed medical journals. Whether you are a healthcare provider, patient, caregiver, an individual working in the healthcare sector, or just a curious person, you can benefit from Your Dose of Cannabis Education.
Wake up every morning and get your dose of unbiased evidence-based cannabis education!
The American College of Obstetricians and Gynecologists as well as the American Academy of Pediatrics recommend against cannabis use during pregnancy. Yes…"maternal impacts of cannabis use may indirectly impact fetal development via increased carbon monoxide levels, increased uterine artery resistance, placental insufficiency, and decreased expression of placental immune-activating genes.""Endocannabinoid receptors are present in the embryo as early as 5 weeks’ gestation, cannabinoid receptors are involved in early synaptogenesis and neural plasticity, and the fetal neuro- developmental period is vital for long-term neurologic outcomes."Very few studies have evaluated the therapeutic use of FDA-approved and/or other nationally-approved cannabinoid-based products for the treatment of ALS. According to an August 2022 publication, "only one cross-over RCT with dronabinol and one parallel RCT with nabiximols have been carried out in patients suffering from ALS. The two trials did not report any improvement in ALS scores and the pooled effect indicated an almost significant effect favouring placebo."Yes, according to a 2024 survey study published in the American College of Rheumatology's journal. The key finding of that study include: 62.5% reported substituting medical cannabis for certain medications, including NSAIDs (54.7%), opioids (48.6%), sleep aids (29.6%), muscle relaxants (25.2%), benzodiazepines (15.5%), and gabapentinoids (10.5%); the reasons given for substituting medical cannabis were fewer side effects (39%), better symptom control (27%), and fewer adverse effects (12%); and participants who substituted medical cannabis reported significant improvements in various symptoms, including pain, sleep, anxiety and joint stiffness.
feed…New to TheAnswerPage? There’s lots we’d like to share with you and we don’t want you to miss a thing! Be sure to register today for “Your Dose of Cannabis Education” emails where you’ll gain valuable insights in small doses that fit your schedule and also be provided direct access to the archived daily content.